C WorldWide Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-47,325
| Closed | -$6.4M | – | 116 |
|
|
2019
Q1 | $6.4M | Sell |
47,325
-4,275
| -8% | -$578K | 0.08% | 48 |
|
|
2018
Q4 | $5.02M | Sell |
51,600
-14,247
| -22% | -$1.39M | 0.07% | 48 |
|
|
2018
Q3 | $9.15M | Sell |
65,847
-9,727
| -13% | -$1.35M | 0.12% | 44 |
|
|
2018
Q2 | $9.38M | Hold |
75,574
| – | – | 0.13% | 42 |
|
|
2018
Q1 | $8.42M | Sell |
75,574
-130
| -0.2% | -$14.5K | 0.13% | 43 |
|
|
2017
Q4 | $9.05M | Sell |
75,704
-6,240
| -8% | -$746K | 0.13% | 49 |
|
|
2017
Q3 | $11.5M | Sell |
81,944
-31,483
| -28% | -$4.42M | 0.16% | 40 |
|
|
2017
Q2 | $13.8M | Buy |
113,427
+74,676
| +193% | +$9.09M | 0.21% | 38 |
|
|
2017
Q1 | $4.7M | Buy |
38,751
+87
| +0.2% | +$10.5K | 0.08% | 56 |
|
|
2016
Q4 | $4.73M | Sell |
38,664
-5,897
| -13% | -$722K | 0.09% | 57 |
|
|
2016
Q3 | $5.46M | Buy |
44,561
+2,600
| +6% | +$319K | 0.1% | 49 |
|
|
2016
Q2 | $4.9M | Buy |
41,961
+400
| +1% | +$46.7K | 0.09% | 48 |
|
|
2016
Q1 | $5.79M | Buy |
41,561
+350
| +0.8% | +$48.7K | 0.11% | 46 |
|
|
2015
Q4 | $7.86M | Hold |
41,211
| – | – | 0.14% | 47 |
|
|
2015
Q3 | $6.45M | Sell |
41,211
-850
| -2% | -$133K | 0.11% | 48 |
|
|
2015
Q2 | $7.6M | Sell |
42,061
-4,600
| -10% | -$832K | 0.11% | 50 |
|
|
2015
Q1 | $8.09M | Hold |
46,661
| – | – | 0.12% | 46 |
|
|
2014
Q4 | $8.63M | Sell |
46,661
-38,969
| -46% | -$7.21M | 0.13% | 41 |
|
|
2014
Q3 | $14.2M | Buy |
+85,630
| New | +$14.2M | 0.21% | 37 |
|